Profile
An experienced corporate lawyer, Lis advises listed and private companies, multinationals, and not-for-profit organisations on their structure, governance, operations and strategy. Her clients appreciate her commitment to building long term relationships and understanding their culture and strategy so as to deliver timely, thoughtful and practical advice.
At a strategic level, Lis collaborates with boards and senior executives on significant transactions — such as capital raisings, restructuring, strategic collaborations and mergers and acquisitions (public and private). Lis’s deep experience and practical insights are particularly appreciated by growing clients who seek her guidance on how to plan and execute these important projects.
Lis also helps organisations review their governance framework so that it is “fit for purpose”, and provides emotionally intelligent advice on engaging with key stakeholders around complex member approvals, or dealing with conflicts of interest. In this, Lis brings additional perspectives as a graduate of the Australian Institute of Company Directors. For listed companies, Lis gives practical direction on meeting continuous disclosure obligations.
At an operational level, Lis guides clients in how to integrate business ethics and legal compliance into “business as usual”, training boards and managers on fulfilling their key legal obligations, such as privacy and directors’ & officers’ duties. Lis also designs contract review frameworks in line with the organisation’s risk appetite as well as drafting and negotiating complex contracts.
Lis’s strong focus on Life Sciences and Healthcare is reflected in her appointment as deputy chair of AusBiotech’s AusMedtech Advisory Group, and as a member of AusBiotech’s State Committee for NSW. Lis has also actively participated in AusBiotech industry projects including AusBiotech’s Guide for Directors of Life Sciences Companies, AusBiotech’s Guide for Investors in Life Sciences Companies and pitching workshops for Life Sciences CEOs. She enjoys being a “connector” between people in her network, to strengthen the Australian life sciences ecosystem.
Expertise
Recognition
“Lis is a wonderful asset to the Australian life sciences community, with a very service-oriented approach to her clients.”
Chambers Asia Pacific Guide: Life Sciences, 2023 edition – Strengths
“She has always been my point person and is always readily available to talk through any prickly topics. And the speed to provide the advice is second to none. Very much appreciated in a competitive market.”
Chambers Asia Pacific Guide: Life Sciences, 2023 edition – Strengths
“Lis Boyce is very commercial, personally engaged, quick to call in further expertise from within the firm where required. Lis has been actively involved in our matters and has helped us resolve several difficult situations with investors relating to contract technicalities, debt and equity maturity, and conversion, adjustment of shareholdings, deal documentation.”
The Legal 500 Asia-Pacific: Corporate and M&A, 2021 edition – Testimonials
Accolades
- Chambers Asia-Pacific Guide – Life Sciences – Band 4 since 2021 edition
- Best Lawyers in Australia – Recognised for Life Sciences Practice (Sydney, AU) – since 2020 edition
- The Legal 500 Asia-Pacific – Recognised ‘Key Lawyer’ for Corporate and M&A – since 2021 edition
Recent deals and media coverage
- Top 10 Most Influential Life Sciences Lawyers in Australia 2023 Revealed – Business Today News, 29 July 2023
- Aerospace engineering company advised on Series B funding round – Lawyers Weekly, 13 September 2022
- AMSL Innovations Pty Ltd’s Series B Equity Funding Round – Global Legal Chronicle, 7 September 2022
- Lindsay Dynan merges with Hatch – Lawyers Weekly, 27 January 2021
- Lindsay Dynan’s Merger with Hatch – Global Legal Chronicle, 22 January 2022
- Piper Alderman recruits health and life sciences partner – Lawyers Weekly, 31 January 2021
Memberships
- Graduate, Australian Institute of Company Directors
- Fellow, Governance Institute of Australia
- Senior Fellow, Financial Services Institute of Australasia
Insights
21 August 2024
Corporate takeovers done lawfully: A guide for unlisted public companies in growth mode
Read More24 March 2023
Webinar Q&As: 2023 ‘Beat the Clock’ Series: Professional skills | The contract review toolkit
Read More13 December 2022
Webinar Q&As: Crisis Management – When it hits the fan… responding to a crisis
Read More15 August 2022
ESG Reporting for Life Sciences Companies (as if saving lives wasn’t enough….)
Read More04 August 2022
Lexology Getting the Deal Through – Data Protection and Privacy, 2023 Edition
Read More14 February 2022
Temporary measures made permanent: Corporations Amendment (Meetings and Documents) Bill 2021 passed by the Senate
Read More14 February 2022
Goodbye Wet-ink – Hello, Electronic Signing: Revisions to the Corporations Act 2001
Read More30 September 2021
COVID-19 testing at home: new regulation to allow rapid antigen self-tests
Read More30 August 2021
COVID-19 rapid antigen tests: complying with advertising and supply requirements
Read More01 June 2020
What happens when a charity’s purpose can’t be amended? Lessons from Bushfire Fundraising and the...
Read More09 April 2020
COVID-19 Stimulus Measures – How is the Federal Government assisting Not-for-Profits?
Read More07 April 2020
Members’ meetings in the Age of COVID-19 – Can members’ meetings of charities that are...
Read MoreCase Studies
21 January 2022